help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Plenat, F.
Right arrow Articles by Duprez, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Plenat, F.
Right arrow Articles by Duprez, A.

American Journal of Pathology, Vol 147, 124-135, Copyright © 1995 by American Society for Investigative Pathology


REGULAR ARTICLES

Cell and tissue distribution of synthetic oligonucleotides in healthy and tumor-bearing nude mice. An autoradiographic, immunohistological, and direct fluorescence microscopy study

F Plenat, N Klein-Monhoven, B Marie, JM Vignaud and A Duprez
Laboratory Pathological Anatomy, Division of Medecine, Vandoeuvre les Nancy, France.

Antisense oligonucleotides have the ability to inhibit individual gene expression in the potential treatment of cancer and viral diseases. However, the way parenterally administered oligonucleotides distribute themselves into healthy tissues or tumors is poorly understood. In this study, the cell and tissue distribution of two modified or unmodified phosphodiester pentadeca-beta-oligonucleotides intravenously administered to healthy or tumor-bearing nude mice was assessed by autoradiography as well as by direct fluorescence and immunoenzymatic histological methods. Resistance of oligonucleotides to degradation by nuclease activity was previously studied in vitro. Using these methods we were able to show the following: 1) within minutes, oligonucleotides permeate all cells and tissues with the exceptions of erythrocytes and intervertebral discs; 2) cell and tissue distribution does not depend on the sequence of the given oligonucleotide; 3) concentration of oligonucleotides is higher within the connective tissue cells than in the interstitial matrix; 4) after uptake, oligomers partition throughout all of the cellular compartments, including at the highest intracellular concentrations in the nuclei; 5) oligonucleotides penetrate easily the tumor cell compartments, oligonucleotide diffusion being unimpeded by the extracellular matrix.


This article has been cited by other articles:


Home page
Toxicol PatholHome page
N. Goebl, B. Berridge, V. J. Wroblewski, and P. L. Brown-Augsburger
Development of a Sensitive and Specific in Situ Hybridization Technique for the Cellular Localization of Antisense Oligodeoxynucleotide Drugs in Tissue Sections
Toxicol Pathol, June 1, 2007; 35(4): 541 - 548.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. P. Ho, M. S. Scully, C. M. Krauthauser, E. J. Wexler, M. D. Stow, J. E. Dinchuk, J. S. Kerr, and P. A. Friedman
Antisense Oligonucleotides Selectively Regulate Aspartyl beta -Hydroxylase and Its Truncated Protein Isoform in Vitro but Distribute Poorly into A549 Tumors in Vivo
J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 795 - 803.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. M. Crooke, M. J. Graham, M. J. Martin, K. M. Lemonidis, T. Wyrzykiewiecz, and L. L. Cummins
Metabolism of Antisense Oligonucleotides in Rat Liver Homogenates
J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 140 - 149.
[Abstract] [Full Text]


Home page
Toxicol PatholHome page
D. K. Monteith, M. J. Horner, N. A. Gillett, M. Butler, R. Geary, T. Burckin, T. Ushiro-Watanabe, and A. A. Levin
Evaluation of the Renal Effects of an Antisense Phosphorothioate Oligodeoxynucleotide in Monkeys
Toxicol Pathol, May 1, 1999; 27(3): 307 - 317.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. J. Graham, S. T. Crooke, D. K. Monteith, S. R. Cooper, K. M. Lemonidis, K. K. Stecker, M. J. Martin, and R. M. Crooke
In Vivo Distribution and Metabolism of a Phosphorothioate Oligonucleotide within Rat Liver after Intravenous Administration
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 447 - 458.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
R. S. Geary, J. M. Leeds, J. Fitchett, T. Burckin, L. Truong, C. Spainhour, M. Creek, and A. A. Levin
Pharmacokinetics and Metabolism in Mice of a Phosphorothioate Oligonucleotide Antisense Inhibitor of C-raf-1 Kinase Expression
Drug Metab. Dispos., November 1, 1997; 25(11): 1272 - 1281.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Qian, S.-H. Chen, E. Von Hofe, and J. M. Gallo
Pharmacokinetics and Tissue Distribution of a DNA-Methyltransferase Antisense (MT-AS) Oligonucleotide and Its Catabolites in Tumor-Bearing Nude Mice
J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 663 - 670.
[Abstract] [Full Text]


Home page
J. Histochem. Cytochem.Home page
K. Lappalainen, R. Miettinen, J. Kellokoski, I. Jaaskelainen, and S. Syrjanen
Intracellular Distribution of Oligonucleotides Delivered by Cationic Liposomes: Light and Electron Microscopic Study
J. Histochem. Cytochem., February 1, 1997; 45(2): 265 - 274.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Society for Investigative Pathology.